Cubist Systematic Strategies’s AbCellera Biologics ABCL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-22,625
| Closed | -$146K | – | 1929 |
|
|
2023
Q2 | $146K | Sell |
22,625
-53
| -0.2% | -$342 | ﹤0.01% | 1743 |
|
|
2023
Q1 | $171K | Sell |
22,678
-145,749
| -87% | -$1.1M | ﹤0.01% | 2267 |
|
|
2022
Q4 | $1.71M | Sell |
168,427
-415,554
| -71% | -$4.21M | 0.01% | 1408 |
|
|
2022
Q3 | $5.78M | Buy |
583,981
+188,649
| +48% | +$1.87M | 0.03% | 712 |
|
|
2022
Q2 | $4.21M | Buy |
395,332
+149,029
| +61% | +$1.59M | 0.03% | 952 |
|
|
2022
Q1 | $2.4M | Sell |
246,303
-16,383
| -6% | -$160K | 0.02% | 1330 |
|
|
2021
Q4 | $3.76M | Buy |
262,686
+225,812
| +612% | +$3.23M | 0.04% | 852 |
|
|
2021
Q3 | $739K | Sell |
36,874
-223,485
| -86% | -$4.48M | 0.01% | 1755 |
|
|
2021
Q2 | $5.73M | Buy |
260,359
+221,809
| +575% | +$4.88M | 0.06% | 456 |
|
|
2021
Q1 | $1.31M | Buy |
+38,550
| New | +$1.31M | 0.02% | 1350 |
|